Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
FRE FME FMEA FME3 Funds Furniture Energy Natural Foods 
United States  USA  |  Screen Global Equities


Processing
Processing. Please wait...

Fresenius Revenue

 
 Companies |  Insiders  | Dashboard  
     

Revenue breakdown for Fresenius

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.

Fresenius

Revenue

=

Money Received

-

Discounts and Returns

=
14.08 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare Fresenius to competition

Fresenius Revenue Assessment

Based on latest financial disclosure Fresenius Medical Care AG Co KGAA reported 14.08 B of revenue. This is 209.49% higher than that of Healthcare sector, and 156.76% higher than that of Hospitals industry, The Revenue for all stocks is 76.39% lower than the firm.

Filter other Stocks by Revenue

Specify Market Cap
Select Revenue Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Fresenius Medical Care AG Co KGAA is rated # 5 in revenue category among related companies. Market size based on revenue of Hospitals industry is currently estimated at about 79.17 Billion. Fresenius retains roughly 14.08 Billion in revenue claiming about 18% of equities under Hospitals industry.
Follow Fresenius Revenue with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Fresenius to your reader
 
    
FME Germany XETRA #DE0005785802DE
Fresenius Medical Care AG Co KGAA
Currency: EUR - Euro
Traded on XETRA Stock Exchange
    
    

Other Fresenius Fundamentals

Return On Equity14.58 %
Return On Asset6.47 %
Profit Margin8.43 %
Operating Margin15.38 %
Current Valuation23.85 B
Shares Outstanding306.71 M
Price to Earning13.58 times
Price to Book1.82 times
Price to Sales1.16 times
Revenue14.08 B
Gross Profit3.83 B
EBITDA2.77 B
Net Income1.19 B
Cash and Equivalents708.94 M
Cash per Share2.31 times
Total Debt8.3 B
Debt to Equity0.85 times
Current Ratio1.93 times
Book Value Per Share29.16 times
Cash Flow from Operations2.04 B
One Year High60.27
One Year Low47.79
Earnings Per Share3.87 times
Number of Employees86.15 K
Market Capitalization16.12 B
Total Asset16.7 B
Retained Earnings3.59 B
Working Capital1.58 B
Current Asset5.35 B
Current Liabilities3.77 B
Z Score0.6
Probability Of Bankruptcy47.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium